Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) Net Margin (2022 - 2026)

Core Laboratories filings provide 5 years of Net Margin readings, the most recent being 0.58% for Q1 2026.

  • On a quarterly basis, Net Margin fell 63.0% to 0.58% in Q1 2026 year-over-year; TTM through Mar 2026 was 5.64%, a 8.0% increase, with the full-year FY2025 number at 5.77%, down 37.0% from a year prior.
  • Net Margin hit 0.58% in Q1 2026 for Core Laboratories, down from 3.71% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 17.96% in Q2 2023 to a low of 0.58% in Q1 2026.
  • Median Net Margin over the past 5 years was 5.87% (2024), compared with a mean of 5.78%.
  • Biggest five-year swings in Net Margin: surged 1204bps in 2023 and later crashed -1092bps in 2024.
  • Core Laboratories' Net Margin stood at 4.69% in 2022, then plummeted by -60bps to 1.9% in 2023, then surged by 206bps to 5.81% in 2024, then tumbled by -36bps to 3.71% in 2025, then crashed by -116bps to 0.58% in 2026.
  • The last three reported values for Net Margin were 0.58% (Q1 2026), 3.71% (Q4 2025), and 10.76% (Q3 2025) per Business Quant data.